NasdaqGS:PHVSPharmaceuticals
Can Rising Losses at Pharvaris (PHVS) Reveal Deeper Challenges in Its Path to Profitability?
On August 12, 2025, Pharvaris N.V. reported its second quarter and six-month financial results, revealing a net loss of €45.48 million and €91.82 million, respectively, both higher than the same periods last year.
The company’s losses per share from continuing operations also increased significantly year-over-year, indicating ongoing financial pressures.
With widening losses driving recent earnings headlines, we’ll explore how this shapes Pharvaris’s investment narrative amid persistent cost...